Tuesday, July 22, 2008

Teva Introduces Lamotrigine Tablets

July 22, 2008 – Teva Pharmaceuticals is pleased to announce the introduction and availability of Lamotrigine Tablets. This product is AB rated and bioequivalent to Lamictal®* Tablets. Lamotrigine Tablets are available in 25 mg and 100 mg strengths, in bottle sizes of 100, and in 150 mg and 200 mg strengths, in bottle sizes of 60.

The details can be read here.

1 comment:

Anonymous said...

I began using this generic drug the
first week in August. Soon after,
I began to experience short term
memory loss and extreme fatigue.
I've been to a neurologist who has
ordered memory/cognitive tests
and also MRI/MRA of the brain.
If all prove negative, I would
assume that the cause is this generic drug and will ask my doctor
to write a script for the brand
name only. I've been on the
brand name for at least 3 years
without a problem. I am a 45 year
old male with no history of memory
loss. My corided arteries are
clear and my stress test came out
fine.